메뉴 건너뛰기




Volumn 19, Issue 2, 2001, Pages 335-341

Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions

Author keywords

Drug failure; Drug therapy; Humans; Hypertension; Patient compliance

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EID: 0035144723     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200102000-00022     Document Type: Article
Times cited : (230)

References (25)
  • 1
    • 0025234906 scopus 로고
    • Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
    • (1990) Lancet , vol.335 , pp. 765-774
    • MacMahon, S.1    Peto, R.2    Cutler, J.3
  • 3
    • 0030713021 scopus 로고    scopus 로고
    • The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
    • (1997) Arch Int Med , vol.157 , pp. 2413-2446
  • 4
    • 0033069767 scopus 로고    scopus 로고
    • World Health Organization-International Society of Hypertension guidelines for the management of hypertension
    • (1999) J Hypertens , vol.17 , pp. 151-183
  • 8
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • HOT study group
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 12
    • 0031730234 scopus 로고    scopus 로고
    • Consequences of intermittent treatment for hypertension: The case for medication compliance and persistence
    • (1998) Am J Managed Care , vol.4 , pp. 1563-1568
    • Cramer, J.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.